Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: ABT-510 in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating ABT-510 for metastatic melanoma has completed. The Mayo Clinic sponsored the study.
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma [Phase 2]
A phase 2 trial evaluating high-dose Interferon alfa plus Interleukin-2 in patients with metastatic kidney cancer and melanoma has completed…
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: TNFerade™ Biologic Plus Radiation for Metastatic Melanoma [Phase 2]
This document reports a Phase 2 trial update evaluating TNFerade Biologic in combination with radiation for metastatic melanoma; the trial s…
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV Melanoma [Phase 1, Phase 2]
This document reports the completion of a Phase 1/Phase 2 clinical trial evaluating an unspecified vaccine therapy for patients with stage I…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors [Phase 1]
A Phase 1 clinical trial update evaluating the combination of paclitaxel and bortezomib in patients with metastatic or unresectable malignan…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Immune Responses To Antigen-Bearing Dendritic Cells in Patients With Malignancy [Phase 1]
Phase 1 trial report updates immune responses to antigen-bearing dendritic cell therapy in patients with melanoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Differential Risks for Melanoma: p16 and DNA Repair
A completed clinical trial update discusses differential melanoma risk related to p16 status and DNA repair mechanisms.
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response [Phase 1]
A completed Phase I trial in melanoma patients evaluating the safety and immune response of a Mouse Tyrp2 DNA vaccine.
-
CLINICAL_TRIALS trial_result · 2011-03-10Clinical Trial Update: Partner Assistance in Learning and Performing Skin Self-Examination [NA]
A completed trial investigated partner-assisted learning to perform skin self-examinations for melanoma. The study results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma [Phase 3]
Phase 3 clinical trial update on a treatment combination for unresectable stage III or stage IV melanoma; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-02-23Clinical Trial Update: A Phase I/II Study of Sunitinib and Dacarbazine [Phase 1, Phase 2]
A Phase I/II trial evaluating the combination of sunitinib and dacarbazine for melanoma was terminated (status: TERMINATED).
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas. [Phase 2]
Phase 2 trial evaluating nilotinib as a first- or second-line treatment for unresectable Stage III melanoma. The provided snippet does not i…
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma [Phase 2]
A Phase 2 study evaluating MDX-010 (ipilimumab) alone and in combination with dacarbazine for metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: A Phase II, Multi-Center, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Sorafenib Given Daily in Combination With Repeated 21-Day Cycles of Dacarbazine (DTIC) Chemotherapy in Subjects With Advanced Metastatic Melanoma [Phase 2]
Phase II study evaluating daily sorafenib in combination with repeated 21-day cycles of dacarbazine in patients with advanced/metastatic mel…
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: Survey Study - Sensitivity Comparison Between MelaFind and Physician Group
Completed clinical trial comparing the sensitivity of MelaFind versus a physician group in detecting melanoma; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma [Phase 2]
This document reports an update on a Phase 2 trial of Imatinib (Gleevec) in selected patients with metastatic melanoma, which has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-13Clinical Trial Update: A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma [Phase 2]
Phase II clinical trial evaluating a combination of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine in patients with advanced …
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating the combination of sorafenib and pegylated interferon α2b in stage IV metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial of a multi-antigen therapeutic vaccine for metastatic melanoma was terminated, with results posted in December 2010.
-
CLINICAL_TRIALS trial_result · 2010-12-14Clinical Trial Update: Nordic Adjuvant IFN Melanoma Trial [Phase 3]
The Nordic adjuvant interferon melanoma trial (Phase 3) has completed. This is a status update indicating the Phase 3 study has finished.
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma [Phase 2]
Phase 2 trial evaluating the immunogenicity of a synthetic melanoma peptide vaccine administered with GM-CSF in combination with systemic lo…
-
CLINICAL_TRIALS trial_result · 2010-10-13Clinical Trial Update: PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) [Phase 3]
Phase 3 trial comparing pegylated interferon alfa-2b (PegIntron) with interferon alfa-2b (IntronA) in CMAJCC Stage II; the study has complet…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Biological Therapy in Treating Patients With Metastatic Melanoma [Phase 1]
This clinical trial update notes the completion status of a Phase 1 study of a biological therapy in patients with metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2010-08-23Clinical Trial Update: Phase 1 Study of MPC-6827 and Temozolomide in Metastatic Melanoma [Phase 1, Phase 2]
Phase 1/2 clinical trial of MPC-6827 with temozolomide for metastatic melanoma has completed its evaluation.
-
CLINICAL_TRIALS trial_result · 2010-08-18Clinical Trial Update: Trial of Surgical Excision Margins in Thick Primary Melanoma [NA]
Completed Karolinska Institutet clinical trial evaluating surgical excision margins in thick primary melanoma.